Innoviva, Inc. INVA Equity Method Investment
Equity Method Investment at other companies
Other financials
Where this comes from
Reported directly by Innoviva, Inc. in its filing.
Tagged under the XBRL concept inva:EquityMethodInvestment.
The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Innoviva, Inc.'s equity method investment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Innoviva, Inc.'s equity method investment?
- Innoviva, Inc. (INVA) reported equity method investment of $351.38M in Q1 2026.
- How has Innoviva, Inc.'s equity method investment changed year-over-year?
- Innoviva, Inc.'s equity method investment increased by 806.9% year-over-year, from $38.74M to $351.38M.
- What is the long-term trend for Innoviva, Inc.'s equity method investment?
- Over 3 years (2022 to 2025), Innoviva, Inc.'s equity method investment has grown at a 70.4% compound annual growth rate (CAGR), from $39.15M to $193.73M.
- What does equity method investment mean?
- This represents the carrying value of investments in entities where the company exercises significant influence but does not have full control. It reflects the company's long-term strategic interest in external healthcare assets or joint ventures. Changes in this balance indicate the company's ongoing commitment to and the performance of its non-consolidated strategic partnerships.